Swiss pharma suspected of delaying generic competition snbchf.com: The United States Food and Drug Administration (FDA) published Thursday a list of pharmaceutical companies that include Basel-based Novartis and Roche, all of which are suspected of hindering the development of generic versions of their own medicines. Over 150 complaints were filed.
explicita
Sem comentários:
Enviar um comentário